Ruilong Peng
Overview
Explore the profile of Ruilong Peng including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
58
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Li K, Wang J, Gao Y, Chen X, Peng R, Li L, et al.
Life Sci
. 2025 Feb;
366-367:123501.
PMID: 39983827
Aims: Traumatic brain injury-induced coagulopathy (TBI-IC) frequently occurs after TBI, exacerbating the severity of TBI and affecting patient prognosis. Benzbromarone (BBR) is commonly used to treat hyperuricemia; however, its protective...
2.
Li L, Peng R, Wang C, Chen X, Gheyret D, Guan S, et al.
Cell Commun Signal
. 2025 Feb;
23(1):70.
PMID: 39923080
Neutrophils are the first responders among peripheral immune cells to infiltrate the central nervous system following a traumatic brain injury (TBI), triggering neuroinflammation that can exacerbate secondary tissue damage. The...
3.
Wang J, Li X, Wang K, Li K, Gao Y, Xu J, et al.
Front Immunol
. 2024 Jun;
15:1361351.
PMID: 38846954
Background: Gliomas constitute a category of malignant tumors originating from brain tissue, representing the majority of intracranial malignancies. Previous research has demonstrated the pivotal role of CLEC7A in the progression...
4.
Zhou Z, Li Y, Peng R, Shi M, Gao W, Lei P, et al.
Neuroreport
. 2024 Mar;
35(6):352-360.
PMID: 38526937
An imbalance of immune/inflammatory reactions aggravates secondary brain injury after traumatic brain injury (TBI) and can deteriorate clinical prognosis. So far, not enough therapeutic avenues have been found to prevent...
5.
Li F, Li L, Peng R, Liu C, Liu X, Liu Y, et al.
Int Immunopharmacol
. 2024 Feb;
130:111674.
PMID: 38387190
Traumatic brain injury (TBI) can induce systemic coagulopathy and inflammation, thereby increasing the risk of mortality and disability. However, the mechanism causing systemic coagulopathy and inflammation following TBI remains unclear....
6.
Zhang H, Gao Y, Wang C, Huang X, Li T, Li K, et al.
Biochem Biophys Res Commun
. 2023 Nov;
688:149065.
PMID: 37979398
Intestinal injury caused by traumatic brain injury (TBI) seriously affects patient prognosis; however, the underlying mechanisms are unknown. Recent studies have demonstrated that ferritinophagy-mediated ferroptosis is involved in several intestinal...
7.
Peng R, Liu X, Wang C, Li F, Li T, Li L, et al.
Biochem Biophys Res Commun
. 2023 Oct;
682:46-55.
PMID: 37801989
Previous studies have proved that cardiac dysfunction and myocardial damage can be found in TBI patients, but the underlying mechanisms of myocardial damage induced by TBI can't be illustrated. We...
8.
Li F, Liu Y, Li L, Peng R, Wang C, Liu C, et al.
Biochem Biophys Res Commun
. 2023 May;
665:141-151.
PMID: 37163934
Traumatic brain injury (TBI) can negatively impact systemic organs, which can lead to more death and disability. However, the mechanism underlying the effect of TBI on systemic organs remains unclear....
9.
Li L, Li F, Bai X, Jia H, Wang C, Li P, et al.
Pharmacol Res
. 2023 May;
192:106791.
PMID: 37156450
Endothelial dysfunction is a key proponent of pathophysiological process of traumatic brain injury (TBI). We previously demonstrated that extracellular vesicles (EVs) released from injured brains led to endothelial barrier disruption...
10.
Gao Y, Zhang H, Wang J, Li F, Li X, Li T, et al.
Int Immunopharmacol
. 2023 Jan;
114:109619.
PMID: 36700781
Traumatic brain injury often causes poor outcomes and has few established treatments. Neuroinflammation and ferroptosis hinder therapeutic progress in this domain. Annexin A5 (A5) has anticoagulant, anti-apoptotic and anti-inflammatory bioactivities....